Tiamulin Drugs Market: North America to Capture Major Share of Global Market
The development of antibiotics has saved countless lives and businesses. The widespread adoption of antibiotics in human and animal husbandry, agriculture, and veterinarians’ practices has led to the growth of the antibiotics market in the region by approximately 300 million USD in 2016.
However, the use of antibiotics in agriculture and animals has led to the emergence of new antibiotic resistances. The emergence of superbugs has further curtailed the growth of the market.
The global antibiotic market is expected to grow at a CAGR of around 6% over the course of the forecast period. North America is the largest region for the antibiotics market, followed by Europe and Asia-Pacific. North America is the leading market for the production of antibiotics, followed by Europe and Asia-Pacific.
In the report, we have segmented the market based on drug type, form, and application. We have also analyzed the market size by geography, with the help of an in-depth analysis of data from primary sources. The key drivers and restraints that affect the market are also discussed in detail in the report.
Read on to know more about the main drivers, challenges, and challenges for the antibiotics market.
Drivers for the Antibiotics Market
The main drivers for the antibiotics market are:
Growth in human and animal health due to the increased adoption of antibiotics for diseases such as urinary calculi, heartburn, arthritis, and more
Avoids use of more expensive and less effective antibiotics, which have led to the rise of antimicrobial resistance
Increasing demands for technological solutions to overcome the growing resistance
Increasing investments in health technologies, including the development of anti-aging peptides and proteins, gene therapy, and more
Poor regulation of the industry, particularly in the areas of health and safety and food and drug assessment
Antibiotics Market: Growing Demand for Food-Based Antibiotics
The growing demand for food-based antibiotics stems from two major factors. First, significant investments are being made in developing human-food-like strains of bacteria and yeast, which can be used to strengthen human health. The leading countries in this regard are China, Brazil, and India. Globally, such investments totaled $80 billion in 2015, and they are expected to reach $100 billion by 2020.
Secondly, the increasing popularity of natural and organic foods is leading to the growth of the foods and drinks with high amounts of biodiversity. Biodiversity, in turn, is believed to confer health benefits, including enhanced immune function and better gut bacteria.
Antibiotics Market: Emerging Threat from Superbugs
The antibiotic resistance problem, also called the “superbug” problem, is a growing concern for the public health community. Superbugs, also called “nasties,” are antibiotic-resistant bacterial and/or viral strains that are more difficult to treat.
The emergence of new antibiotics is a major concern for the global drug market. The market is expected to grow significantly over the forecast period, driven by the demand for new antibiotics and the increasing popularity of natural and organic foods.
Antibiotic resistance is a concern for all industries, including the food and drink, pharmaceutical, and biotechnology sectors. To fight the superbug problem, scientists and health experts recommend the following steps:
Development of new antibiotics that target the root cause of the problem.
Increase in research and development efforts to develop new human and animal health products and drugs that target the root cause of the problem.
Improvement of current manufacturing processes to ensure a reduction in the risk of drug resistance.
Use of modern technologies, such as the development of molecular mapping and genomic analysis, to monitor the distribution of the various antibiotic resistance markers in the body and the environment.
Increase in the global monitoring of resistance to detect emerging resistance trends.
Mergers and Acquisitions in the Antibiotics Industry
In the last two years, several companies have merged or acquired other companies in the biopharmaceutical and food & beverage industries, which have had a major impact on the global food and drink market.
In the food & drink industry, the following mergers and acquisitions were undertaken by the year-end 2016:
In the industrial sector, the following mergers and acquisitions were undertaken by the year-end 2016:
Algen Corporation, a manufacturer of pharmaceuticals and medical devices, was acquired by Amyris, a leader in the development of innovative medical products.
Beatrice, a leading food and beverage company, was acquired by Danone, the world’s leading milk provider.
Nestlé S.A., the world’s leading food and beverage company, was acquired by the Swatch Group.
Teva Pharmaceutical Industries, a manufacturer of over-the-counter (OTC) drugs, was acquired by the Warner Entertainment Company.
Waterford, a leading manufacturer of glass and ceramic products, was acquired by the Estée Lauder Companies.
Antibiotics are very important in medicine and are used to treat a variety of conditions. They are also used as a fertilizing agent, which may sound odd to people who are unaware of its uses.
The growing use of antibiotics in agriculture and animals has led to the emergence of new antibiotic Resistances. The emergence of superbugs has further curtailed the growth of the market.
The main drivers, challenges, and restraints that affect the market are discussed above. Antibiotics market is expected to grow at a rapid rate over the next three years. The growth is mainly driven by the rising demand for food-based antibiotics and the increasing popularity of natural and organic foods.
So, review the report, get the full picture, and plan your strategy to take advantage of this growth opportunity.